Navigation Links
Fox Chase Cancer Center's Ning Wong receives ASCO Cancer Foundation Career Development Award
Date:5/14/2008

The American Society of Clinical Oncology Cancer Foundation has selected Yu-Ning Wong, M.D., M.S.C.E., of Fox Chase Cancer Center, as one of 13 clinicians to receive a 2008 Career Development Award. Career Development Awards are presented to physicians in their second, third or fourth year as full-time faculty members in an academic setting. This award marks the third time ASCO has honored Wong's accomplishments since she began her professional career in oncology in 2002.

Wong is an attending physician in Fox Chase Cancer Center's department of medical oncology and holds a dual appointment as an associate member of the Center's divisions of medical science and population science. Her clinical interests include genitourinary malignancies such as kidney, bladder, prostate and testicular cancers. Wong also conducts health services research including cost-effectiveness analysis and research on treatment outcomes.

"I believe it is essential for physicians to understand how we care for cancer patients as a society," said Wong. "I study large national databases to measure the outcomes of men with prostate cancer, and I study outcomes of treatment for colon cancer and breast cancer. I enjoy these endeavors because they encourage me to think about problems from many different angles, an important aspect of being a medical oncologist."

Each of this year's Clinical Development Award winners will receive a three-year grant totaling $200,000 to establish an independent clinical cancer research program. This is the third award ASCO has given Wong. In 2005, she was awarded a Young Investigator Award, which provides grants to leading young clinical oncology researchers in a broad range of specialties worldwide. In 2004, she received an ASCO Merit Award given to fellows who submit high-quality abstracts selected for presentation at the ASCO Annual Meeting.

"We are currently in the longest period of flat and declining federal funding for cancer research to date, and without appropriate investment, the opportunity to develop better treatments for cancer care will be lost or delayed," said Joseph S. Bailes, MD, chair of The ASCO Cancer Foundation Board of Directors. "The ASCO Cancer Foundation supports progress in cancer by funding researchers at all stages of their profession enabling oncology's best and brightest to pursue promising research initiatives."

A board-certified medical oncologist, Dr. Wong joined the Fox Chase medical staff in July 2005 after completing a three-year fellowship in hematology and oncology at the Fox Chase-Temple Cancer Center.

Wong has a bachelor's degree in liberal arts from the University of Virginia and an M.D. from the Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey in Piscataway, N.J. She completed her residency in internal medicine at Thomas Jefferson University Hospital in Philadelphia. Wong also has a master's of science degree in clinical epidemiology from the University of Pennsylvania.

In addition to her ASCO membership, Wong serves on two disease-specific executive committees for the National Comprehensive Cancer Networkone on the outcomes database in colorectal cancer and one on the outcomes database in breast cancer.


'/>"/>

Contact: Karen Mallet
karen.mallet@fccc.edu
414-312-7085
Fox Chase Cancer Center
Source:Eurekalert

Related medicine news :

1. Somanetics Announces Share Repurchase Program Increased by $15 Million
2. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend, Authorizes Share Repurchase Program and Announces Election of New Officers
3. DaVita Board of Directors Increases Share Repurchase Authorization
4. AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company
5. US Army Purchases SeQuals Cutting-Edge Oxygen Generation Technology for MRAP Deployment
6. HealthSouth to Purchase The Rehabilitation Hospital of South Jersey
7. Patient Centered Primary Care Collaborative Releases New Guidelines for Health Care Purchasers
8. Saratoga Hospital Purchases Three IDC DR Systems
9. Somanetics Announces Share Repurchase Program
10. Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting
11. Health Fitness Announces $2.5 Million Stock Repurchase Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... , ... February 13, 2016 , ... ... Outlook’s top Clinical Data Management Solution Providers list for its expertise in eClinical ... and domain expertise to serve the technology needs of global clients. DDi provides ...
(Date:2/12/2016)... Antonio, TX (PRWEB) , ... February 12, 2016 , ... ... love, as expressed in Blue SKies Buddha, the biography of Rama - Dr. Frederick ... fact a love story, the love of a Buddhist teacher for teaching and helping ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed to introduce ... from U.S. universities who will draw from Siemens’ deep knowledge of product ...
(Date:2/12/2016)... ... ... , Back to the Future , Feb. 25, 2016 — 11:00 a.m. – 12:30 p.m. ... learn from history are doomed to repeat it.” , An analysis of CDRH’s enforcement actions ... takes time. , Take a close look at the warning letters the agency sent ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Each year, the ... be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical therapists ... new therapy products in action, learn more about their chosen field and network with ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Feb. 12, 2016  SI-BONE, Inc., a medical device company that ... a minimally invasive surgical (MIS) device indicated for fusion for certain ... Inc. (NGS), the Medicare Administrative Contractor (MAC) covering the states of ... Maine , Massachusetts , ... New York , Rhode Island , ...
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, 2016 ... today announced they will form a partnership to ... medicine in cancer. The goal of the collaboration ... with Macrogen,s high-throughput Next Generation Sequencing capabilities toward ... Laboratory Improvement Amendments (CLIA) of 1988 by the ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
Breaking Medicine Technology: